Inventor · disambiguated record
Christine A. White
Also filed as: WHITE CHRISTINE · WHITE CHRISTINE A
13 granted patents·3 pending applications·475 citations·filing 1984–2017
94Inventor score
Files withBIOGEN IDEC INC3BIOGEN INC3IDEC PHARMA CORP3SALK INST FOR BIOLOGICAL STUDI2BENTLY NEVADA CORP1
Top patents by PatentIndex Score
16 records- 0196US6846476B2Treatment of B-cell associated diseasesIDEC PHARMA CORP·Filed 2001·Granted Jan 25, 2005·100 cites·12 claims
- 0292US8557244B1Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibodyWHITE CHRISTINE·Filed 2000·Granted Oct 15, 2013·54 cites·2 claims
- 0390US7682612B1Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibodyBIOGEN IDEC INC·Filed 1999·Granted Mar 23, 2010·88 cites·60 claims
- 0488US8206711B2Treatment of chronic lymphocytic leukemia using anti-CD20 antibodiesWHITE CHRISTINE A·Filed 2009·Granted Jun 26, 2012·23 cites·9 claims
- 0587US6405139B1System for monitoring plant assets including machineryBENTLY NEVADA CORP·Filed 1998·Granted Jun 11, 2002·74 cites·16 claims
- 0687US5814525APiezoelectric biosensor with a ladder polymer substrate coatingSANDIA CORP·Filed 1996·Granted Sep 29, 1998·85 cites·17 claims
- 0783US8821873B2Treatment of diffuse large-cell lymphoma with anti-CD20 antibodyBIOGEN IDEC INC·Filed 2013·Granted Sep 2, 2014·4 cites·5 claims
- 0879US9504744B2Treatment of diffuse large-cell lymphoma with anti-CD20 antibodyBIOGEN INC·Filed 2014·Granted Nov 29, 2016·2 cites·16 claims
- 0978US10400043B2Treatment of diffuse large-cell lymphoma with anti-CD20 antibodyBIOGEN INC·Filed 2017·Granted Sep 3, 2019·1 cites·1 claims
- 1073US6451284B1Clinical parameters for determining hematologic toxicity prior to radioimmunotheraphyIDEC PHARMA CORP·Filed 2000·Granted Sep 17, 2002·11 cites·52 claims
- 1167US7195750B2Clinical parameters for determining hematologic toxicity prior to radioimmunotherapyBIOGEN IDEC INC·Filed 2002·Granted Mar 27, 2007·4 cites·30 claims
- 1261US5032521AMonoclonal antibody specific for a mammary tumor cell surface antigenSALK INST FOR BIOLOGICAL STUDI·Filed 1987·Granted Jul 16, 1991·22 cites·9 claims
- 1359US2005112060A1Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combinationIDEC PHARMA CORP·Filed 2003·Application pending·0 cites
- 1458US2017037139A1Treatment of diffuse large-cell lymphoma with anti-cd20 antibodyBIOGEN INC·Filed 2016·Application pending·0 cites
- 1552US2007148714A1Clinical Parameters for Determining Hematologic Toxicity Prior to RadioimmunotherapyRAESTETTER WILLIAM·Filed 2007·Application pending·0 cites
- 1646US4628032AMonoclonal antibody specific for a mammary tumor cytoplasmic antigenSALK INST FOR BIOLOGICAL STUDI·Filed 1984·Granted Dec 9, 1986·7 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Christine A. White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →